Cartesian Therapeutics (RNAC) Tops Q2 EPS by 50c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: RNAC) | Delayed: 6.08 -0.19 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.27 | 52 Week High | $ | |||
| Open | $6.28 | 52 Week Low | $ | |||
| Day High | $6.55 | P/E | N/A | |||
| Day Low | $6.01 | EPS | $ | |||
| Volume | 201,517 | |||||
